100 related articles for article (PubMed ID: 191933)
1. Studies of serum testosterone and its reduction products.
Strickland AL; Apland M
South Med J; 1977 Apr; 70(4):426-8. PubMed ID: 191933
[TBL] [Abstract][Full Text] [Related]
2. Two different pathogenetic mechanisms may play a role in acne and in hirsutism.
Toscano V; Balducci R; Bianchi P; Guglielmi R; Mangiantini A; Rossi FG; Colonna LM; Sciarra F
Clin Endocrinol (Oxf); 1993 Nov; 39(5):551-6. PubMed ID: 8252744
[TBL] [Abstract][Full Text] [Related]
3. Simultaneous radioimmunoassay of tesosterone, dihydrotestosterone, 5 alpha-androstane-3alpha, 17beta-diol and 5alpha-androstane-3beta, 17beta-diol in the plasms of adult male rats.
Corpéchot C; Eychenne B; Robel P
Steroids; 1977 Apr; 29(4):503-16. PubMed ID: 867448
[TBL] [Abstract][Full Text] [Related]
4. Plasma 5alpha androstanediol: an androgen marker of hirsuitism in women.
Meikle AW; Stringham JD; Dolman LI; Lagerquist LG; Tyler FH
Trans Assoc Am Physicians; 1976; 89():133-45. PubMed ID: 1020119
[No Abstract] [Full Text] [Related]
5. Is 3 alpha-androstanediol a marker of peripheral hirsutism?
Toscano V; Sciarra F; Adamo MV; Petrangeli E; Foli S; Caiola S; Conti C
Acta Endocrinol (Copenh); 1982 Feb; 99(2):314-20. PubMed ID: 6460409
[TBL] [Abstract][Full Text] [Related]
6. The determination of 5alpha-androstane-3alpha, 17beta-diol in human plasma by radioimmunoassay.
Laband P; Tresguerres JA; Lisboa BP; Volkwein U; Tamm J
Acta Endocrinol (Copenh); 1978 Aug; 88(4):778-86. PubMed ID: 581118
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of testosterone, 5alpha-androstan-17beta-ol-3-one, 5alpha-androstane-3alpha,17beta-diol and 5alpha-androstane-3beta,17beta-diol in plasma of adult male rabbits by radioimmunoassay(1).
Schanbacher BD; Ewing LL
Endocrinology; 1975 Oct; 97(4):787-92. PubMed ID: 1193006
[TBL] [Abstract][Full Text] [Related]
8. Serum 5alpha-androstane-3alpha,17beta-diol, androsterone, and testosterone concentrations in the male rat. Influence of age and gonadotropin stimulation.
Moger WH
Endocrinology; 1977 Apr; 100(4):1027-32. PubMed ID: 837871
[TBL] [Abstract][Full Text] [Related]
9. Effect of short- and long-term dexamethasone on 3 alpha-androstanediol glucuronide in hirsute women.
Meikle AW; Odell WD
Fertil Steril; 1986 Aug; 46(2):227-31. PubMed ID: 3015694
[TBL] [Abstract][Full Text] [Related]
10. Elevated production and metabolic clearance rates of androgens in morbidly obese women.
Samojlik E; Kirschner MA; Silber D; Schneider G; Ertel NH
J Clin Endocrinol Metab; 1984 Nov; 59(5):949-54. PubMed ID: 6480813
[TBL] [Abstract][Full Text] [Related]
11. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
Carmina E; Lobo RA
Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
[TBL] [Abstract][Full Text] [Related]
12. Normal and elevated 3 alpha-androstanediol glucuronide concentrations in women with various causes of hirsutism and its correlation with degree of hirsutism and androgen levels.
Pang S; Wang M; Jeffries S; Riddick L; Clark A; Estrada E
J Clin Endocrinol Metab; 1992 Jul; 75(1):243-8. PubMed ID: 1535633
[TBL] [Abstract][Full Text] [Related]
13. 3 alpha, 17 beta-androstanediol glucuronide in plasma. A marker of androgen action in idiopathic hirsutism.
Horton R; Hawks D; Lobo R
J Clin Invest; 1982 May; 69(5):1203-6. PubMed ID: 7068855
[TBL] [Abstract][Full Text] [Related]
14. Clinical usefulness of plasma androstanediol glucuronide measurements in women with idiopathic hirsutism.
Kirschner MA; Samojlik E; Szmal E
J Clin Endocrinol Metab; 1987 Oct; 65(4):597-601. PubMed ID: 3654909
[TBL] [Abstract][Full Text] [Related]
15. Comparison between testosterone enanthate-induced azoospermia and oligozoospermia in a male contraceptive study. III. Higher 5 alpha-reductase activity in oligozoospermic men administered supraphysiological doses of testosterone.
Anderson RA; Wallace AM; Wu FC
J Clin Endocrinol Metab; 1996 Mar; 81(3):902-8. PubMed ID: 8772548
[TBL] [Abstract][Full Text] [Related]
16. Evidence for the importance of peripheral tissue events in the development of hirsutism in polycystic ovary syndrome.
Lobo RA; Goebelsmann U; Horton R
J Clin Endocrinol Metab; 1983 Aug; 57(2):393-7. PubMed ID: 6223045
[TBL] [Abstract][Full Text] [Related]
17. Outcome of long-term treatment with the 5 alpha-reductase inhibitor finasteride in idiopathic hirsutism: clinical and hormonal effects during a 1-year course of therapy and 1-year follow-up.
Castello R; Tosi F; Perrone F; Negri C; Muggeo M; Moghetti P
Fertil Steril; 1996 Nov; 66(5):734-40. PubMed ID: 8893676
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous estimation of four plasma androgens before and after dynamic tests in women with hirsutism: correlation with long-term therapy.
Sciarra F; Toscano V; Concolino G; Sorcini G; Marocchi A; Conti C
Horm Res; 1976; 7(1):16-27. PubMed ID: 1002113
[TBL] [Abstract][Full Text] [Related]
19. Serum levels of 3alpha-androstanediol glucuronide in young women with polycystic ovary syndrome, idiopathic hirsutism and in normal subjects.
Meczekalski B; Slopien R; Warenik-Szymankiewicz A
Eur J Obstet Gynecol Reprod Biol; 2007 May; 132(1):88-92. PubMed ID: 16979812
[TBL] [Abstract][Full Text] [Related]
20. The influence of androgens on insulin resistance.
Shoupe D; Lobo RA
Fertil Steril; 1984 Mar; 41(3):385-8. PubMed ID: 6230259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
